Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Oakmark (Harris)

Loomis Sayles Small Cap Growth Fund Class N (LSSNX)

Ticker LSSNX · · Holdings as of Jun 30, 2026

Expense ratio
0.82%$82/yr per $10k
5-yr return
+2.6%annualized
1-yr return
+3.8%as of Dec 2025
Net assets
$2.3Ball share classes
Holdings
97

Bottom line

Is LSSNX a good fund? The bottom line

LSSNX is the Class N share class of Loomis Sayles Small Cap Growth Fund, a managed small-cap mutual fund from Oakmark (Harris).

Its expense ratio is 0.82% — about $82 a year on every $10,000 invested, cheaper than 73% of small-cap funds we track.

It returned +3.8% over one year, +2.6% a year over five years, +10.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $2.3 billion in net assets and 97 holdings, its largest position is Fixed Income Clearing Corp. (2.6%) and the top 10 make up 20.2% of the portfolio.

What to watch

  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What LSSNX invests in

The Funds investment objective is long-term capital growth from investments in common stocks or other equity securities.

The Fund normally will invest at least 80% of its net assets (plus any borrowings made for investment purposes) in the equity securities of small-capitalization companies, including preferred stocks, warrants, securities convertible into common or preferred stocks and other equity-like interests in an entity. Currently, the Fund defines a small-capitalization company to be one whose market capitalization falls within the capitalization range of the Russell 2000 Index, an index that tracks stocks of 2,000 of the smallest U.S. companies. The Fund may invest the rest of its assets in companies of any size, including large-capitalization companies. In deciding which securities to buy and sell, Loomis Sayles typically seeks to identify companies that it believes have distinctive products, technologies, or services; dynamic earnings growth; prospects for high levels of profitability; and…

From the fund's prospectus (filed Jan 27, 2026).

LSSNX performance

Average annual total returns
1 yr5 yr10 yr
LSSNX+3.8%+2.6%+10.1%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full LSSNX performance history →

What LSSNX costs

On a $10,000 investment, LSSNX's 0.82% expense ratio costs about $82 a year. The prospectus estimates $1,014 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full LSSNX fee table →

LSSNX top 10 holdings

#Holding% of fund
1Fixed Income Clearing Corp.2.56%
2Ligand Pharmaceuticals Inc2.20%
3ESCO Technologies Inc2.14%
4RBC Bearings Inc2.04%
5Mercury Systems Inc1.99%
6Extreme Networks Inc1.96%
7ATI Inc1.87%
8MACOM Technology Solutions Holdings Inc1.87%
9Advanced Energy Industries Inc1.85%
10Establishment Labs Holdings Inc1.74%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 20.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to LSSNX

More funds like LSSNX →

LSSNX FAQ

What is the expense ratio of LSSNX?
LSSNX's expense ratio is 0.82%, which works out to about $82 a year for every $10,000 invested. The prospectus estimates total costs of $1,014 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is LSSNX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does LSSNX hold?
LSSNX's largest holdings are Fixed Income Clearing Corp. (2.6%), Ligand Pharmaceuticals Inc (2.2%), ESCO Technologies Inc (2.1%), RBC Bearings Inc (2.0%), Mercury Systems Inc (2.0%). It holds 97 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is LSSNX's 5-year return?
LSSNX returned +2.6% a year over the five years ending Dec 31, 2025, and +10.1% a year over ten years. Past performance does not guarantee future results.
Who manages LSSNX?
LSSNX is offered by Oakmark (Harris) through Loomis Sayles Funds II.